The largest vertically integrated cannabis company in Europe, Curaleaf International, a division of Curaleaf Holdings, has announced the acquisition of Setubal, Portugal-based Clever Leaves’ EU-GMP certified cannabis processing facility. This tactical move will provide Curaleaf a competitive advantage in the quickly expanding European market and greatly increase its capacity for processing flowers. Curaleaf wants to address the rising demand for high-quality cannabis products in Europe by streamlining operations and enhancing cultivation capacity.
Improving operations and accelerating processes
Firstly, Curaleaf Holdings is the parent business of Curaleaf International. Curaleaf is a trusted brand with a goal to improve lives via the power of plants. The company has built a solid reputation for quality, knowledge, and dependability. The business serves both the medical and adult-use sectors through its brands, which include Curaleaf, Select, and Grassroots. Curaleaf International, combines extraction and production methods with cutting-edge cultivation practices and scientific research.
For Curaleaf International, the acquisition of Clever Leaves’ cutting-edge processing facility represents a chance to streamline operations. The facility has over 900 square metres of GMP industrial space and 750 square metres of storage space. It will operate as the point for processing the flower grown at Curaleaf’s Terra Verde cultivation facility in Alcochete, Portugal. This integration will make the seed-to-sale process more effective. It will also provide a supply that complies with EU-GMP standards to suit the demands of European consumers.
The focus of Curaleaf International on increasing Terra Verde’s cultivation capacity corresponds with the expected growth of the European cannabis market, particularly in significant areas like the UK and Germany. Curaleaf hopes to expand its presence and market position in these areas by utilising the recently purchased processing plant. Thus, Curaleaf is prepared to contribute to the responsible and healthy growth of the European cannabis market with a dedication to provide patients and consumers with premium cannabis products.
Looking ahead and Curaleaf International’s future
Certainly, the purchasing of Clever Leaves’ processing plant represents a crucial turning point in Curaleaf International’s European expansion plan. Curaleaf is ready for expanding demand for medicinal cannabis products in the European market. It is expanding its flower processing capacity. Curaleaf is dedicated to delivering high-quality cannabis products and promoting responsible growth throughout Europe and beyond even as the business keeps changing.